All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY1251 | Anti-GNAI1 (7H7) h(41BB-CD3ζ) CAR, pCDCAR1 | Other | 7H7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1252 | Anti-GNAI1 (L5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Cattle, Guineapig | L5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1253 | Anti-GNAI1 (CBLG1-1391) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Cattle, Guineapig | CBLG1-1391 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1254 | Anti-GNAI1 (CBLG1-1395) h(41BB-CD3ζ) CAR, pCDCAR1 | Cattle, Human, Rat | CBLG1-1395 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1255 | Anti-GNAI1 (CBLG1-1403) h(41BB-CD3ζ) CAR, pCDCAR1 | Cattle, Human, Rat | CBLG1-1403 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2891 | Anti-GNAI1(7H7) h(CD28-CD3ζ) CAR, pCDCAR1 | Other | 7H7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2892 | Anti-GNAI1(L5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Cattle, Guineapig | L5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2893 | Anti-GNAI1(CBLG1-1391) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Cattle, Guineapig | CBLG1-1391 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2894 | Anti-GNAI1(CBLG1-1395) h(CD28-CD3ζ) CAR, pCDCAR1 | Cattle, Human, Rat | CBLG1-1395 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2895 | Anti-GNAI1(CBLG1-1403) h(CD28-CD3ζ) CAR, pCDCAR1 | Cattle, Human, Rat | CBLG1-1403 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION